NCT06028464View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of BI 1810631 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

December 8, 2023

Study Completion Date

December 8, 2023

Conditions
Healthy
Interventions
DRUG

BI 1810631

BI 1810631

DRUG

Carbamazepine

Carbamazepine

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06028464 - A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of BI 1810631 in the Blood | Biotech Hunter | Biotech Hunter